Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Unintended Consequences in Cancer Care Delivery Created by the Medicare Part B Proposal: Is the Clinical Rationale for the Experiment Flawed?

Gordan L, Grogg A, Blazer M, Fortner B.

J Oncol Pract. 2017 Feb;13(2):e139-e151. doi: 10.1200/JOP.2016.016550. Epub 2016 Dec 28.

PMID:
28029298
2.

Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from US community oncology clinics.

Feinberg BA, Jolly P, Wang ST, Fortner B, Scott J, Gilmore J, Neary MP, Duh MS.

Med Oncol. 2012 Jun;29(2):786-94. doi: 10.1007/s12032-011-9922-z. Epub 2011 Apr 9.

PMID:
21479699
3.

Utility of routine nurse assessment of the risk of chemotherapy-induced febrile neutropenia.

Moore K, Fortner B.

Can Oncol Nurs J. 2010 Spring;20(2):75-9.

PMID:
20572430
4.

Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma.

Elfiky AA, Cho DC, McDermott DF, Rosenberg JE, Fortner B, AntrĂ s L, Chen K, Sheng Duh M, Jayawant SS, Oh WK, Atkins MB, Choueiri TK.

Urol Oncol. 2011 Nov-Dec;29(6):756-63. doi: 10.1016/j.urolonc.2010.01.008. Epub 2010 May 6.

PMID:
20451414
5.

Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices.

Raptis A, Duh MS, Wang ST, Dial E, Fanourgiakis I, Fortner B, Paley C, Mody-Patel N, Corral M, Scott J.

Transfusion. 2010 Jan;50(1):190-9. doi: 10.1111/j.1537-2995.2009.02361.x. Epub 2009 Aug 28.

PMID:
19719471
6.

Health economic analysis of the burden of infusion reactions on patients, caregivers, and providers.

Fortner B, Viale PH.

Oncology (Williston Park). 2009 Feb;23(2 Suppl 1):31-6. Review.

7.

The benefits and challenges of using computer-assisted symptom assessments in oncology clinics: results of a qualitative assessment.

Mark TL, Johnson G, Fortner B, Ryan K.

Technol Cancer Res Treat. 2008 Oct;7(5):401-6.

PMID:
18783291
8.

Evaluation of a tablet PC technology to screen and educate oncology patients.

Mark TL, Fortner B, Johnson G.

Support Care Cancer. 2008 Apr;16(4):371-8. Epub 2007 Aug 18.

PMID:
17704955
9.

Baseline evaluation of the AIM Higher Initiative: establishing the mark from which to measure.

Johnson GD, Moore K, Fortner B.

Oncol Nurs Forum. 2007 May;34(3):729-34.

PMID:
17573332
10.

Editorial: the challenge of electronically captured patient-reported outcomes.

Fortner B.

J Oncol Pract. 2007 May;3(3):120-1. doi: 10.1200/JOP.0731503. No abstract available.

11.
12.

Impact of less frequent injections on patients, caregivers, and practices.

Fortner B.

Oncology (Williston Park). 2006 Jul;20(8 Suppl 6):33-8. Review.

13.

Validation of the Cancer Care Monitor items for physical symptoms and treatment side effects using expert oncology nurse evaluation.

Fortner B, Baldwin S, Schwartzberg L, Houts AC.

J Pain Symptom Manage. 2006 Mar;31(3):207-14.

14.

Baseline evaluation of assessment, information, and management patterns in a national quality improvement project.

Johnson G, Fortner B, Moore K, Tauer KT, Zhu L, Schwartzberg LS; AIM Higher Working Group.

J Support Oncol. 2005 Nov-Dec;3(6 Suppl 4):36-7. No abstract available.

PMID:
16355562
15.
16.

A classroom mind/body wellness intervention for older adults with chronic illness: comparing immediate and 1-year benefits.

Rybarczyk B, DeMarco G, DeLaCruz M, Lapidos S, Fortner B.

Behav Med. 2001 Spring;27(1):15-27.

PMID:
11575169
17.

Personal and professional factors and suicide intervention skills.

Neimeyer RA, Fortner B, Melby D.

Suicide Life Threat Behav. 2001 Spring;31(1):71-82.

PMID:
11326770

Supplemental Content

Loading ...
Support Center